Human duffy blood group alloantigen system influences the measurement of monocyte chemoattractant protein-1 (MCP-1) in serum but not in plasma

ISSN: 14336510
7Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

Background: We explored whether the Asp42Gly polymorphism (rs12075) in the DARC gene represents a confounding factor in the interpretation of monocyte chemoattractant protein-1 (MCP-1) concentration in circulating blood. Methods: MCP-1 concentration in serum and plasma were measured in 278 healthy Caucasian participants who are representative of our geographic area. The rs12075 genotype distribution was also assessed in this population. Results: Plasma MCP-1 concentration did not vary among the rs12075 polymorphism derived genotypes [in pg/mL, AA: 171.9 (100.2-287.2), AG: 178.9 (105.1-326.4) and GG: 173.7 (94.4-405.7)]. However, there were significant increases in serum MCP-1 related to the presence of the A allele [in pg/mL, AA: 334.6 (180.4-756.4), AG: 299.1 (166.1-634.9) and GG: 249.1 (149.3-578.1)]. Conclusions: These findings limit the value of circulating MCP-1 as a biomarker and apparently indicate a pathophysiological role for silent chemokine receptors.

Cite

CITATION STYLE

APA

Aragonès, G., Ercilla, A., Barreda, M., Rull, A., Beltrán-DEBÓN, R., Rodríguez-Gallego, E., … Joven, J. (2012). Human duffy blood group alloantigen system influences the measurement of monocyte chemoattractant protein-1 (MCP-1) in serum but not in plasma. Clinical Laboratory, 58(1–2), 185–188.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free